{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:01:43Z","timestamp":1767146503337,"version":"build-2238731810"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,8,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Once-daily administration of phosphodiesterase type 5 inhibitors has been shown to correct erectile dysfunction (ED).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To evaluate the long-term efficacy and safety after once-daily oral administration of udenafil 75 mg in men with ED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This clinical trial was an open-label, fixed-dose, 24-week extension study (DA8159_EDDL_III) of a 24-week double-blinded efficacy and safety study of once-daily udenafil (parent study: DA8159_EDD_III). Subjects received udenafil 75 mg once daily for 24 weeks during this extension study, and the follow-up visit occurred during the 4-week ED treatment-free period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>Subjects were asked to complete the International Index of Erectile Function questionnaire and the Global Assessment Questionnaire at the 24-week extension and after the 4-week ED treatment-free period, and the development of adverse drug reactions was investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 302 subjects were enrolled in this extension study. Improvement was shown with an increased erectile function (EF) domain score compared with baseline (14.60 \u00b1 4.57) at extension week 48 (23.98 \u00b1 5.44) and a slight increase in EF domain score compared with the last time point (week 24) of the parent study (P &amp;lt; .001). The Global Assessment Questionnaire showed a high improvement rate of 95.4% at the extension 48-week time point. For shift to normal, almost half the subjects (45.1%) recovered \u201cnormal\u201d EF, and 14.2% of subjects reported normal erections after the 4-week ED treatment-free period. The occurrence rate of adverse drug reactions was 8%, which consisted mainly of flushing and headache.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Once-daily dosing of udenafil 75 mg showed excellent efficacy and safety with long-term administration and allowed a more spontaneous sexual life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.jsxm.2016.05.011","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T15:35:15Z","timestamp":1466264115000},"page":"1263-1269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Phase 3 Study to Evaluate the 1-Year Efficacy and Safety of Udenafil 75 mg Once Daily in Patients with Erectile Dysfunction"],"prefix":"10.1093","volume":"13","author":[{"given":"Ki Hak","family":"Moon","sequence":"first","affiliation":[{"name":"Department of Urology \u00a0 \u00a0 , Daegu, , Korea"},{"name":"College of Medicine \u00a0 \u00a0 , Daegu, , Korea"},{"name":"Yeungnam University \u00a0 \u00a0 , Daegu, , Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sae Woong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Seoul, , Korea"},{"name":"The Catholic University of Korea College of Medicine \u00a0 , Seoul, , Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Du Geon","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 \u00a0 , Seoul, , Korea"},{"name":"College of Medicine \u00a0 \u00a0 , Seoul, , Korea"},{"name":"Korea University \u00a0 \u00a0 , Seoul, , Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Je Jong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 \u00a0 , Seoul, , Korea"},{"name":"College of Medicine \u00a0 \u00a0 , Seoul, , Korea"},{"name":"Korea University \u00a0 \u00a0 , Seoul, , Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam Cheol","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Busan, , Korea"},{"name":"Pusan National University School of Medicine \u00a0 , Busan, , Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Won","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 \u00a0 , Seoul, , Korea"},{"name":"Samsung Medical Center \u00a0 \u00a0 , Seoul, , Korea"},{"name":"Sungkyunkwan University School of Medicine \u00a0 \u00a0 , Seoul, , Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Seung","family":"Paick","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Seoul, , Korea"},{"name":"Seoul National University Medical School \u00a0 , Seoul, , Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai Young","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 \u00a0 , Seoul, , Korea"},{"name":"Asan Medical Center \u00a0 \u00a0 , Seoul, , Korea"},{"name":"Ulsan University School of Medicine \u00a0 \u00a0 , Seoul, , Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Sik","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Seoul, , Korea"},{"name":"Ewha Womans University School of Medicine \u00a0 , Seoul, , Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwon Sik","family":"Min","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 \u00a0 , Pusan, , Korea"},{"name":"College of Medicine \u00a0 \u00a0 , Pusan, , Korea"},{"name":"Inje University \u00a0 \u00a0 , Pusan, , Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Kwan","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Jeonju, , Korea"},{"name":"Chonbuk National University Medical School \u00a0 , Jeonju, , Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Yul","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 \u00a0 , Seoul, , Korea"},{"name":"College of Medicine \u00a0 \u00a0 , Seoul, , Korea"},{"name":"Hallym University \u00a0 \u00a0 , Seoul, , Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Seok","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Daegu, , Korea"},{"name":"Catholic University of Daegu School of Medicine \u00a0 , Daegu, , Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwangsung","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Gwangju, , Korea"},{"name":"Chonnam National University Medical School \u00a0 , Gwangju, , Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,8,1]]},"reference":[{"key":"2024032602344451900_bib1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/BF02977007","article-title":"Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159","volume":"25","author":"Doh","year":"2002","journal-title":"Arch Pharm Res"},{"key":"2024032602344451900_bib2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.eururo.2007.06.048","article-title":"Daily administration of phosphodiesterase type 5 inhibitors for urological and nonurological indications","volume":"52","author":"Bella","year":"2007","journal-title":"Eur Urol"},{"key":"2024032602344451900_bib3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/jsm.12253","article-title":"A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy","volume":"11","author":"Kim","year":"2014","journal-title":"J Sex Med"},{"key":"2024032602344451900_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.eururo.2006.02.052","article-title":"Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"50","author":"Porst","year":"2006","journal-title":"Eur Urol"},{"key":"2024032602344451900_bib5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/jsm.12818","article-title":"Treatment satisfaction of men and partners following switch from on-demand phosphodiesterase type 5 inhibitor therapy to tadalafil 5\u2009mg once daily","volume":"12","author":"Burns","year":"2015","journal-title":"J Sex Med"},{"key":"2024032602344451900_bib6","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.HYP.0000068202.42431.CC","article-title":"PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers","volume":"41","author":"Kimura","year":"2003","journal-title":"Hypertension"},{"key":"2024032602344451900_bib7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.urology.2012.12.068","article-title":"Effect of chronic low-dose tadalafil on penile cavernous tissues in diabetic rats","volume":"81","author":"Mostafa","year":"2013","journal-title":"Urology"},{"key":"2024032602344451900_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4111\/kju.2015.56.2.99","article-title":"Current status of penile rehabilitation after radical prostatectomy","volume":"56","author":"Kim","year":"2015","journal-title":"Korean J Urol"},{"key":"2024032602344451900_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eururo.2008.02.034","article-title":"Endothelial rehabilitation: the impact of chronic PDE5 inhibitors on erectile function and protein alterations in cavernous tissue of diabetic rats","volume":"54","author":"De Young","year":"2008","journal-title":"Eur Urol"},{"key":"2024032602344451900_bib10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1743-6109.2008.01014.x","article-title":"The PDE5 inhibitor sildenafil increases circulating endothelial progenitor cells and CXCR4 expression","volume":"6","author":"Foresta","year":"2009","journal-title":"J Sex Med"},{"key":"2024032602344451900_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.ijir.3901295","article-title":"The effect of PDE5 inhibition on the erectile function in streptozotocin-induced diabetic rats","volume":"17","author":"Ahn","year":"2005","journal-title":"Int J Impot Res"},{"key":"2024032602344451900_bib12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.ijir.3901331","article-title":"The effect of DA-8159, a novel PDE5 inhibitor, on erectile function in the rat model of hypercholesterolemic erectile dysfunction","volume":"17","author":"Kang","year":"2005","journal-title":"Int J Impot Res"},{"key":"2024032602344451900_bib13","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2605.2005.00537.x","article-title":"Chronic administration of phosphodiesterase 5 inhibitor improves erectile and endothelial function in a rat model of diabetes","volume":"28","author":"Ahn","year":"2005","journal-title":"Int J Androl"},{"key":"2024032602344451900_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.eururo.2011.03.025","article-title":"Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"60","author":"Chen","year":"2011","journal-title":"Eur Urol"},{"key":"2024032602344451900_bib15","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/jsm.12862","article-title":"Efficacy of once-daily administration of udenafil for 24 weeks on erectile dysfunction: results from a randomized multicenter placebo-controlled clinical trial","volume":"12","author":"Moon","year":"2015","journal-title":"J Sex Med"},{"key":"2024032602344451900_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.ijir.3901496","article-title":"Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US","volume":"19","author":"Rajfer","year":"2007","journal-title":"Int J Impot Res"},{"key":"2024032602344451900_bib17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1365-2125.2008.03107.x","article-title":"Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects","volume":"65","author":"Kim","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"2024032602344451900_bib18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1745-7262.2007.00233.x","article-title":"Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: a randomized trial","volume":"9","author":"Sommer","year":"2007","journal-title":"Asian J Androl"},{"key":"2024032602344451900_bib19","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1111\/j.1743-6109.2008.00935.x","article-title":"Long-term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction","volume":"5","author":"Porst","year":"2008","journal-title":"J Sex Med"},{"key":"2024032602344451900_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.ijir.3900527","article-title":"Long-term efficacy and safety of oral Viagra (sildenafil citrate) in men with erectile dysfunction and the effect of randomised treatment withdrawal","volume":"12","author":"Christiansen","year":"2000","journal-title":"Int J Impot Res"}],"updated-by":[{"DOI":"10.1016\/j.jsxm.2017.11.003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000}}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609516302557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609516302557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/13\/8\/1263\/48193813\/jsm_13_8_1263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/13\/8\/1263\/48193813\/jsm_13_8_1263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T22:46:52Z","timestamp":1711406812000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/13\/8\/1263\/6940333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,1]]},"references-count":20,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,1]]},"published-print":{"date-parts":[[2016,8,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2016.05.011","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,8]]},"published":{"date-parts":[[2016,8,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Phase 3 Study to Evaluate the 1-Year Efficacy and Safety of Udenafil 75 mg Once Daily in Patients With Erectile Dysfunction","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2016.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016, International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}